Invention Grant
- Patent Title: 2-aminopyridine compounds
-
Application No.: US14437561Application Date: 2013-10-02
-
Publication No.: US09834541B2Publication Date: 2017-12-05
- Inventor: Kai Schiemann , Frank Stieber , Julian Blagg , Aurelie Mallinger , Dennis Waalboer , Christian Rink , Simon Ross Crumpler
- Applicant: Merck Patent GmbH , CANCER RESEARCH TECHNOLOGY LIMITED
- Applicant Address: GB London DE Darmstadt
- Assignee: CANCER RESEARCH TECHNOLOGY LIMITED,MERCK PATENT GMBH
- Current Assignee: CANCER RESEARCH TECHNOLOGY LIMITED,MERCK PATENT GMBH
- Current Assignee Address: GB London DE Darmstadt
- Agency: Millen White Zelano and Branigan, PC
- Agent John Sopp; Csaba Henter
- Priority: EP12006952 20121027
- International Application: PCT/EP2013/002966 WO 20131002
- International Announcement: WO2014/063778 WO 20140501
- Main IPC: C07D471/10
- IPC: C07D471/10 ; A61K31/444 ; A61K31/4545 ; C07D401/04 ; C07D401/14 ; A61K31/5377 ; A61K31/499 ; A61K31/4709 ; C07D417/14 ; C07D491/10 ; C07D498/10
Abstract:
The invention provides novel substituted 2-aminopyridine compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases such as cancer, inflammatory or degenerative diseases.
Public/Granted literature
- US20150353548A1 2-AMINOPYRIDINE COMPOUNDS Public/Granted day:2015-12-10
Information query
